Anti-TIGIT in PD-L1–High Advanced Non–Small Cell Lung Cancer: Insights From SKYSCRAPER-01 and the Path Forward
Journal of Clinical Oncology · 01.09.2026 · 44 (25) · 2366-2370
DOI: 10.1200/jco-26-00935 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Clinical Oncology, erschienen am 01.09.2026. Verfasst von Chang Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzho…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
- Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University,…
ORCID-Profile: Chang Lu, Ying-Long Peng, Ming-Yi Yang, Qing Zhou
Zitieren
APA
Lu, C., Peng, Y. L., Yang, M. Y., & Zhou, Q. (2026). Anti-TIGIT in PD-L1–High Advanced Non–Small Cell Lung Cancer: Insights From SKYSCRAPER-01 and the Path Forward. Journal of Clinical Oncology, 44(25), 2366-2370. https://doi.org/10.1200/jco-26-00935
Vancouver
Lu C, Peng YL, Yang MY, Zhou Q. Anti-TIGIT in PD-L1–High Advanced Non–Small Cell Lung Cancer: Insights From SKYSCRAPER-01 and the Path Forward. Journal of Clinical Oncology. 2026;44(25):2366-2370. doi:10.1200/jco-26-00935
BibTeX
@article{Lu2026,
author = {Lu, Chang and Peng, Ying-Long and Yang, Ming-Yi and Zhou, Qing},
title = {Anti-TIGIT in PD-L1–High Advanced Non–Small Cell Lung Cancer: Insights From SKYSCRAPER-01 and the Path Forward},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {25},
pages = {2366--2370},
doi = {10.1200/jco-26-00935}
}
EUVIMED